시장보고서

상품코드

1808854

세계의 심장 보철 기기 시장 : 제품별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Cardiac Prosthetic Devices Market, By Product, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 08월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심장 보철 기기 시장 규모는 2024년에 72억 9,201만 달러로 평가되었고 2025-2032년에 걸쳐 CAGR 7.10%로 확대될 전망입니다.

심장 보철 기기는 심장, 동맥, 정맥과 같은 심장 혈관계의 일부를 작동시키기 위해 기능 장애 및 손상된 심장 판막을 교체 및 복구하는 의료 장치입니다. 이들은 이식 가능한 장치이며, 정상적인 심장 혈관 장기와 똑같이 작동하고, 심장 내의 적절한 혈류를 회복시키며, 심실의 팽창과 수축을 촉진하고, 그 결과 심장 기능 전체를 개선합니다. 심장 보철 기기를 심장 혈관 모니터링 시스템과 함께 사용하면 수술 절차를 향상시키는 데 도움이 될 수 있습니다.

심장 보철 기기 시장 - 시장 역학

심혈관 질환의 유병률 증가가 시장 성장의 원동력

심혈관 질환의 유병률 증가는 심장 보철 기기 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환(CVD)은 관상 동맥 질환, 심장 마비, 뇌졸중 등 심장과 혈관에 영향을 미치는 질환군입니다. 건강에 해로운 생활 습관, 높은 비만률, 식생활 교란, 운동 부족, 높은 스트레스 수준 및 노화는 모두 심혈관 질환 증가에 기여합니다. 심장 보철 기기는 심장의 기능과 구성요소를 지원하거나 교체하여 이러한 질병을 관리하는 데 도움이 됩니다. 예를 들어, 2024년 1월, 영국의 심장 혈관 연구 자선단체 영국심장재단(British Heart Foundation)의 데이터에 따르면 영국에서는 약 760만명이 심장 및 순환기계 질환을 앓고 있음이 밝혀졌습니다. 여기에는 약 400만 명의 남성과 360만 명의 여성이 포함됩니다. 이 질병은 영국의 전체 사망자 수의 약 27%를 차지하며, 그 결과 매년 17만 명 이상 하루에 약 480명(약 3분에 1명)이 사망하고 있습니다.

심장 보철 기기 시장 - 세분화 분석

세계의 심장 보철 기기 시장은 제품별, 지역별로 구분됩니다.

시장은 제품에 따라 심장 밸브, 조직 밸브, 경피적 카테터 밸브, 기계 밸브, 심장 박동기, 이식 가능한 심장 박동기, 체외 박동기로 분류됩니다. 기계 밸브는 2025년에 가장 큰 수익을 창출하는 하위 부문 중 하나로 예상됩니다. 제조에 사용되는 내구성있는 원료는 환자에게 평생 솔루션을 제공함으로써 시장의 성장을 지원합니다. 또한, 고분자 재료는 일반적으로 원재료로 사용되어 기계 밸브와 관련된 임상 문제를 완화합니다. 또한 기계 밸브는 반복 수술의 필요성이 적고, 이는 목표 시장을 강화하는 추가 요인이 될 것으로 예측됩니다.

심장 보철 기기 시장 - 지리적 인사이트

북미는 심혈관 질환의 유병률 상승과 인구 고령화로 2025년 심장 보철 기기 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 심장 관련 질환이 보편화됨에 따라 심장 판막, 심박 조율기, 이식 가능한 제세동기와 같은 장비에 대한 수요가 증가합니다. 게다가 이 지역의 헬스케어 제도는 양질의 의료 제공을 우선시하고 있으며, 의료기기에 대한 환급 지원은 시장 성장에 크게 기여하고 있습니다. 게다가 혁신적이고 침범성이 낮은 보철 기기의 개발을 목표로 하는 R&D는 시장에 큰 이익을 제공합니다.

아시아태평양은 예측 기간 동안 높은 CAGR로 성장할 것으로 예측됩니다. 이는 주로 이 지역에서 대상 질환의 유병률이 우려할 정도로 상승하여 사망률이 증가하고 있기 때문입니다. 그 결과, 아시아태평양의 주요 선도기업은 대상 인구의 요구를 충족시킬 큰 기회를 가지고 있습니다.

심장 보철 기기 시장 - 경쟁 구도

심장 보철 기기 시장은 경쟁이 치열하고, Medtronic, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, Inc. 등의 주요 의료기기 제조업체가 기계 밸브 및 생체 밸브, 경피적 카테터 밸브 대체 시스템 등 폭넓은 제품을 제공합니다. 이 회사들은 저침습 수술, 경피적 카테터 대동맥 판막 대체술(TAVR) 기술, 환자 특유의 임플란트 설계에 중점을 두고 기술 혁신에서 경쟁하고 있습니다. 전략적 제휴, 규제 당국의 승인, 제품의 상시화가 중요한 경쟁 전략인 한편, 아시아태평양과 라틴아메리카에서의 심혈관 질환 유병률의 상승과 심장 치료에 대한 액세스 향상이 시장 성장을 가속하고 경쟁을 격화시키고 있습니다.

개요
- 제품별 부문 점유율 분석
- 심장 밸브
- 조직 밸브
  - 스텐트식 조직밸브
  - 스텐트리스 조직 밸브
- 경피적 카테터 밸브
- 기계 밸브
- 페이스메이커
- 임베디드형 페이스메이커
  - 단강형 배터리 페이스메이커
  - 이강형 배터리 페이스메이커
  - 삼강형 배터리 페이스메이커
- 체외식 페이스메이커

제8장 심장 보철 기기 시장 : 지역별

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제9장 주요 벤더 분석 - 심장 보철 기기 업계

경쟁 벤치마킹
- 경쟁 대시보드
- 경쟁 포지셔닝
기업 프로파일
- Medtronic, Inc
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- St. Jude Medical, Inc
- Siemens Healthcare GmbH
- Abbott Vascular
- Sorin Group.
- 기타

제10장 애널리스트의 종합적 전망

CSM 25.09.30

Cardiac Prosthetic Devices Market size was valued at US$ 7,292.01 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Cardiac prosthetic devices are medical devices that replace and repair malfunctioning or damaged heart valves to help parts of the cardiovascular system such as the heart, arteries, or veins function. These are implantable devices that function exactly like normal cardiovascular organs, restoring proper blood flow within the heart, facilitating ventricular filling and contractions, and thus improving overall heart function. The use of cardiac prosthetics in conjunction with cardiovascular monitoring systems aids in the improvement of surgical techniques.

Cardiac Prosthetic Devices Market- Market Dynamics

Increased prevalence of cardiovascular diseases drives market growth

The rising prevalence of cardiovascular diseases is expected to fuel the growth of the cardiac prosthetic device market. Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. Unhealthy lifestyles, high obesity rates, poor dietary habits, a lack of exercise, high stress levels, and an aging population all contribute to an increase in cardiovascular disease. Cardiac prosthetic devices help manage these diseases by supporting or replacing heart functions or components. For instance, in January 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million people in the UK suffer from heart and circulatory diseases. This includes approximately 4 million men and 3.6 million women. These conditions account for approximately 27% of all deaths in the UK, resulting in more than 170,000 deaths each year, or approximately 480 deaths per day--roughly one death every three minutes.

Cardiac Prosthetic Devices Market- Key Insights

According to our research analyst's analysis, the global market is expected to grow at a compound annual growth rate (CAGR) of approximately 7.10% during the 2025-2032 forecast period.

According to product segmentation, mechanical valves are expected to hold the largest market share in 2025

On the basis of region, North America was the leading revenue generator in 2025

Cardiac Prosthetic Devices Market- Segmentation Analysis:

The Global Cardiac Prosthetic Devices Market is segmented on the basis of Product, and Region.

The market is divided into seven categories based on Product: Heart valves, Tissue valve, Transcatheter valve, Mechanical valve, Pacemakers, Implantable pacemakers, and External pacemakers. Mechanical valves is one of the largest revenue-generating subsegments in 2025. The durable raw materials used in manufacturing support their growth by providing patients with a lifelong solution. Furthermore, polymeric materials are commonly used as raw materials, reducing the clinical issues associated with mechanical valves. With this type of valve, there is less need for repeated surgeries, which is expected to be an additional factor in enhancing the target market.

Cardiac Prosthetic Devices Market- Geographical Insights

North America will have the largest share of the cardiac prosthetic devices market in 2025, owing to rising prevalence of cardiovascular diseases and an aging population. As heart-related conditions become more common, the demand for devices like heart valves, pacemakers, and implantable defibrillators increases. Furthermore, the region's healthcare system prioritizes quality healthcare delivery, and reimbursement support for medical devices contributes significantly to market growth. Furthermore, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are greatly benefiting the market.

Asia Pacific is expected to grow at a lucrative CAGR over the forecast period. This is primarily due to the alarming rise in the prevalence of target diseases in this region, which is increasing the mortality rate. As a result, there is a tremendous opportunity for key industry players in the Asia Pacific region to meet the unmet needs of the target population.

Cardiac Prosthetic Devices Market- Competitive Landscape:

The cardiac prosthetic devices market is highly competitive, with major medical device companies such as Medtronic, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, and St. Jude Medical, Inc. offering a wide range of products including mechanical and biological heart valves, as well as transcatheter valve replacement systems. These companies compete on innovation, emphasizing minimally invasive procedures, transcatheter aortic valve replacement (TAVR) technology, and patient-specific implant designs. Strategic collaborations, regulatory approvals, and product launches are important competitive strategies, while rising cardiovascular disease prevalence and increased access to cardiac care in Asia-Pacific and Latin America drive market growth and intensify competition.

Recent Developments:

In April 2025, Abbott released clinical trial results from its TACTIC-AF study, which assessed the efficacy of its novel dual-chamber leadless pacemaker system. Positive interoperability data has accelerated regulatory pathways in the US and Europe, indicating the acceptance of next-gen leadless pacing technologies with broader applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic, Inc
Edwards Lifesciences Corporation
Boston Scientific Corporation
St. Jude Medical, Inc
Siemens Healthcare GmbH
Abbott Vascular
Sorin Group.
Others

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Heart valves
Tissue valve
Stented tissue valve
Stentless tissue valve
Transcatheter valve
Mechanical valve
Pacemakers
Implantable pacemakers
Single-Chamber Battery Pacemaker
Dual-Chamber Battery Pacemaker
Triple-Chamber Battery Pacemaker
External pacemakers

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cardiac Prosthetic Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cardiac Prosthetic Devices Market Snippet by Product
- 2.1.2. Cardiac Prosthetic Devices Market Snippet by Country
- 2.1.3. Cardiac Prosthetic Devices Market Snippet by Region
2.2. Competitive Insights

3. Cardiac Prosthetic Devices Key Market Trends

3.1. Cardiac Prosthetic Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cardiac Prosthetic Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cardiac Prosthetic Devices Market Opportunities
3.4. Cardiac Prosthetic Devices Market Future Trends

4. Cardiac Prosthetic Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cardiac Prosthetic Devices Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Cardiac Prosthetic Devices Market Landscape

6.1. Cardiac Prosthetic Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cardiac Prosthetic Devices Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Heart valves
- 7.1.3. Tissue valve
  - 7.1.3.1. Stented tissue valve
  - 7.1.3.2. Stentless tissue valve
- 7.1.4. Transcatheter valve
- 7.1.5. Mechanical valve
- 7.1.6. Pacemakers
- 7.1.7. Implantable pacemakers
  - 7.1.7.1. Single-Chamber Battery Pacemaker
  - 7.1.7.2. Dual-Chamber Battery Pacemaker
  - 7.1.7.3. Triple-Chamber Battery Pacemaker
- 7.1.8. External pacemakers

8. Cardiac Prosthetic Devices Market- By Geography

8.1. Introduction
- 8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
8.2. North America
- 8.2.1. Overview
- 8.2.2. Cardiac Prosthetic Devices Key Manufacturers in North America
- 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.2.5. U.S.
  - 8.2.5.1. Overview
  - 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.2.6. Canada
  - 8.2.6.1. Overview
  - 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3. Europe
- 8.3.1. Overview
- 8.3.2. Cardiac Prosthetic Devices Key Manufacturers in Europe
- 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.5. Germany
  - 8.3.5.1. Overview
  - 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.6. UK
  - 8.3.6.1. Overview
  - 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.7. France
  - 8.3.7.1. Overview
  - 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.8. Italy
  - 8.3.8.1. Overview
  - 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.9. Spain
  - 8.3.9.1. Overview
  - 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.10. The Netherlands
  - 8.3.10.1. Overview
  - 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.11. Sweden
  - 8.3.11.1. Overview
  - 8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.12. Russia
  - 8.3.12.1. Overview
  - 8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.13. Poland
  - 8.3.13.1. Overview
  - 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.3.14. Rest of Europe
  - 8.3.14.1. Overview
  - 8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
- 8.4.1. Overview
- 8.4.2. Cardiac Prosthetic Devices Key Manufacturers in Asia Pacific
- 8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.5. China
  - 8.4.5.1. Overview
  - 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.6. India
  - 8.4.6.1. Overview
  - 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.7. Japan
  - 8.4.7.1. Overview
  - 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.8. South Korea
  - 8.4.8.1. Overview
  - 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.9. Australia
  - 8.4.9.1. Overview
  - 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.10. Indonesia
  - 8.4.10.1. Overview
  - 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.11. Thailand
  - 8.4.11.1. Overview
  - 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.12. Philippines
  - 8.4.12.1. Overview
  - 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.4.13. Rest of APAC
  - 8.4.13.1. Overview
  - 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5. Latin America (LATAM)
- 8.5.1. Overview
- 8.5.2. Cardiac Prosthetic Devices Key Manufacturers in Latin America
- 8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.5. Brazil
  - 8.5.5.1. Overview
  - 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.6. Mexico
  - 8.5.6.1. Overview
  - 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.7. Argentina
  - 8.5.7.1. Overview
  - 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.8. Colombia
  - 8.5.8.1. Overview
  - 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.5.9. Rest of LATAM
  - 8.5.9.1. Overview
  - 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa (MEA)
- 8.6.1. Overview
- 8.6.2. Cardiac Prosthetic Devices Key Manufacturers in Middle East and Africa
- 8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.5. Saudi Arabia
  - 8.6.5.1. Overview
  - 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.6. UAE
  - 8.6.6.1. Overview
  - 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.7. Israel
  - 8.6.7.1. Overview
  - 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.8. Turkey
  - 8.6.8.1. Overview
  - 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.9. Algeria
  - 8.6.9.1. Overview
  - 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.10. Egypt
  - 8.6.10.1. Overview
  - 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 8.6.11. Rest of MEA
  - 8.6.11.1. Overview
  - 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Cardiac Prosthetic Devices Industry

9.1. Competitive Benchmarking
- 9.1.1. Competitive Dashboard
- 9.1.2. Competitive Positioning
9.2. Company Profiles
- 9.2.1. Medtronic, Inc
- 9.2.2. Edwards Lifesciences Corporation
- 9.2.3. Boston Scientific Corporation
- 9.2.4. St. Jude Medical, Inc
- 9.2.5. Siemens Healthcare GmbH
- 9.2.6. Abbott Vascular
- 9.2.7. Sorin Group.
- 9.2.8. Others

10. 360 Degree AnalystView

11. Appendix

11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us